GOG-3098 | TroFuse-20 Clinical Trial Update
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
GOG-3098 | TroFuse-20 Clinical Trial Update
-
Narrated by:
-
Written by:
About this listen
In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as second‑ or third‑line therapy for patients with recurrent or metastatic cervical cancer.
★ Support this podcast ★
adbl_web_anon_alc_button_suppression_c
No reviews yet